Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Vaughan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Research|July 1, 1990
Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cellsT Gessner, L A Vaughan, B C Beehler, et al.
Journal of the American Dietetic Association|November 1, 1995
Blood pressure responses of white men with hypertension to two low-sodium metabolic diets with different levels of dietary calciumW A Levey, M M Manore, L A Vaughan, et al.
Photochemistry and Photobiology|November 24, 1999
Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.
Cancer Research|October 27, 1997
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyB W Henderson, D A Bellnier, W R Greco, et al.
Bone Marrow Transplantation|June 29, 2010
Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCTC E Lucid, B N Savani, B G Engelhardt, et al.
Photochemistry and Photobiology|November 1, 1995
The validation of a new vascular damage assay for photodynamic therapy agentsD A Bellnier, W R Potter, L A Vaughan, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Cancer Research|February 17, 2000
Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateB W Henderson, T M Busch, L A Vaughan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Research|July 1, 1990
Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cellsT Gessner, L A Vaughan, B C Beehler, et al.
Journal of the American Dietetic Association|November 1, 1995
Blood pressure responses of white men with hypertension to two low-sodium metabolic diets with different levels of dietary calciumW A Levey, M M Manore, L A Vaughan, et al.
Photochemistry and Photobiology|November 24, 1999
Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.
Cancer Research|October 27, 1997
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyB W Henderson, D A Bellnier, W R Greco, et al.
Bone Marrow Transplantation|June 29, 2010
Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCTC E Lucid, B N Savani, B G Engelhardt, et al.
Photochemistry and Photobiology|November 1, 1995
The validation of a new vascular damage assay for photodynamic therapy agentsD A Bellnier, W R Potter, L A Vaughan, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Cancer Research|February 17, 2000
Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateB W Henderson, T M Busch, L A Vaughan, et al.
Pageof 2